BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2003
View Archived Issues
NNC-77-0074 stimulates insulin release and inhibits glucagon secretion
Read More
rAHF-PFM reported effective and safe in the management of hemophilia A
Read More
New oxytocin antagonists and their use in preterm labor, dysmenorrhea, etc.
Read More
Manufacturing approval granted for pitavastatin
Read More
Akzo Nobel describes novel ERbeta antagonists in recent patent
Read More
Akzo Nobel presents new androgenic agents
Read More
Novel PPAR agonists prepared and tested by Indian team
Read More
VR-004 shows efficacy in phase IIa erectile dysfunction trial
Read More
Piperazine antidiabetic and antiobesity agents in Shionogi research pipeline
Read More
U. of Oklahoma researchers identify novel proapoptotic antitumor compounds
Read More
Rigel completes phase I/II study of R-112 for allergic rhinitis
Read More
New M3-selective muscarinic antagonists and their use described by Spanish scientists
Read More
Helsinn acquires Gelclair rights from Sinclair
Read More
Further positive results reported from phase Ib trial of Cancer Vac immunotherapy
Read More
Glucokinase activators: a novel class of antidiabetic agents
Read More
Antitumor activity of the novel coxib CS-706 (R-109339) in mice
Read More
SkyePharma licenses European Depocyte rights to Mundipharma
Read More
L-Lysine protease inhibitor with a unique resistance profile
Read More
MediciNova studying potential of SOCC-specific inhibitors for cancer
Read More
Nonpeptide T-20-like HIV entry inhibitors identified by New York Blood Center
Read More
Austrianova's cell therapy receives European orphan drug status
Read More
Tipranavir/ritonavir combination therapy in HIV infection
Read More
Recombinant human GH reported to induce changes in the lipid metabolism of HIV-infected patients
Read More
Nihon Shinyaku discontinues development of NS-7
Read More
NPS and Forest settle pending arbitration
Read More
